William E. Kennard - 02 Jan 2025 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Taylor Jansen, Authorized Signer
Issuer symbol
MET
Transactions as of
02 Jan 2025
Net transactions value
+$43,752
Form type
4
Filing time
06 Jan 2025, 16:39:55 UTC
Previous filing
18 Dec 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $43,752 +535 +1.3% $81.78 41,907 02 Jan 2025 Direct F1
holding MET Common Stock 10 02 Jan 2025 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.